Antibiotic Susceptibility Patterns among Indonesian Adults Hospitalized with Pneumonia
Downloads
Introduction: Pneumonia continues to be a global issue with significant morbidity and mortality rates. Increased multidrug-resistant (MDR) bacterial pneumonia, aging populations, chronically ill patients, and inadequate initial antibiotic therapy increase hospitalized pneumonia patients' morbidity and mortality. This study aimed to analyze the microbiological pattern and choose a therapy based on local antibiotic susceptibility patterns.
Methods: From January 2020 to December 2022, a retrospective cross-sectional study was conducted on hospitalized pneumonia patients at Haji General Hospital, Surabaya, Indonesia. Data from medical records were gathered to illustrate patient features, bacterial culture, and antimicrobial susceptibility tests. This study included 172 patients. In this study, no specific statistical analysis was performed. The data were reported as a percentage (%).
Results: The patients were mostly 56-65 years old (36.6%) and male (55.2%). The most common comorbidities were cardiovascular disease (17.3%), and the others were diabetes mellitus (14.0%), cerebral vascular attack (CVA) (10.7%), and coronavirus infection (8.9%). Based on the sputum culture, the bacteria identified were Klebsiella pneumoniae (25.0%), Pseudomonas aeruginosa (20.9%), Acinetobacter baumannii (15.7%), and Escherichia coli (11.6%). The most common bacteria isolated from sputum cultures was Klebsiella pneumoniae, which was more susceptible to amikacin and meropenem.
Conclusion: Only amikacin was an antibiotic susceptible to four primary pathogens. Rates of resistance to ciprofloxacin and ceftriaxone were high, and these empiric antibiotics should be used with caution in these patients.
Hyams C, Begier E, Gonzalez MG, et al. Incidence of Acute Lower Respiratory Tract Disease Hospitalisations, Including Pneumonia, among Adults in Bristol, UK, 2019, Estimated Using Both a Prospective and Retrospective Methodology. BMJ Open 2022; 12: e057464. [PubMed]
Hyams C, Challen R, Begier E, et al. Incidence of Community Acquired Lower Respiratory Tract Disease in Bristol, UK during the COVID-19 Pandemic: A Prospective Cohort Study. Lancet Reg Heal Eur 2022; 21: 100473. [PubMed]
Carey E, Blankenhorn R, Chen P, et al. Non-Ventilator associated Hospital Acquired Pneumonia Incidence and Health Outcomes among U.S. Veterans from 2016-2020. Am J Infect Control 2022; 50: 116–119. [PubMed]
Hu Y, Han Y, Yu C, et al. The Hospitalization Burden of All-Cause Pneumonia in China: A Population-Based Study, 2009-2017. Lancet Reg Heal West Pacific 2022; 22: 100443. [PubMed]
Sari DP, Maulana A, Astiani R. Clinical Characteristics Patients Pneumonia with Diabetes Mellitus at General Hospital Jakarta, Indonesia. J Drug Deliv Ther; 12. Epub ahead of print 15 November 2022. [Journal]
Islam S, Akand AR, Nova TT, et al. Sensitivity Patterns of Bacterial Pathogens Isolated from Blood Cultures of Under-Five Children with Pneumonia and Clinical Sepsis. Life (Basel, Switzerland); 11. Epub ahead of print May 2021. [PubMed]
Santoso P, Sung M, Hartantri Y, et al. MDR Pathogens Organisms as Risk Factor of Mortality in Secondary Pulmonary Bacterial Infections among COVID-19 Patients: Observational Studies in Two Referral Hospitals in West Java, Indonesia. Int J Gen Med 2022; 15: 4741–4751. [PubMed]
Andayani N, Mahdani W, Nisyra M, et al. Distribution and Antibacterial Susceptibility Pattern of Isolated Bacteria from Endotracheal Aspirates among Ventilator-Assisted Pneumonia Patients in Indonesia. Narra J 2023; 3: e149. [Journal]
Sitompul PA, Indriani R, Rusli A, et al. Antimicrobial Sensitivity Pattern from Hospitalized Pneumonia Patients in National Referral Infectious Disease Hospital in Indonesia. Adv Med 2022; 2022: 3455948. [PubMed]
Radulescu M, Gant V. Gram-Negative Pulmonary Infections - Advances in Epidemiology and Diagnosis. Curr Opin Pulm Med 2023; 29: 168–173. [PubMed]
Kreitmann L, Gaudet A, Nseir S. Ventilator-Associated Pneumonia in Immunosuppressed Patients. Antibiot (Basel, Switzerland); 12. Epub ahead of print February 2023. [PubMed]
Subagdja MFM, Sugianli AK, Prodjosoewojo S, et al. Antibiotic Resistance in COVID-19 with Bacterial Infection: Laboratory-Based Surveillance Study at Single Tertiary Hospital in Indonesia. Infect Drug Resist 2022; 15: 5849–5856. [PubMed]
Ramos DA, Alzate JA, Gómez GAM, et al. Empirical Treatment and Mortality in Bacteremia due to Extended Spectrum β-Lactamase Producing Enterobacterales (ESβL-E), a Retrospective Cross-Sectional Study in a Tertiary Referral Hospital from Colombia. Ann Clin Microbiol Antimicrob 2023; 22: 13. [PubMed]
Llor C, Hoyos Mallecot Y, Moragas A, et al. New Paradigms on Antibiotic Recommendations for Community-Acquired Infections in Spain. Aten Primaria 2023; 55: 102648. [PubMed]
Zawiah M, Khan A, Abu Farha R, et al. Diagnosis and Treatment of Stroke associated Pneumonia: Qualitative Exploration of Clinicians' Practice. Electron J Gen Med 2023; 20: em454. [Journal]
Naito K, Yamasaki K, Yatera K, et al. Bacteriological Incidence in Pneumonia Patients with Pulmonary Emphysema: A Bacterial Floral Analysis Using the 16S Ribosomal RNA Gene in Bronchoalveolar Lavage Fluid. Int J Chron Obstruct Pulmon Dis 2017; Volume 12: 2111–2120. [PubMed]
Liu Y-N, Zhang Y-F, Xu Q, et al. Infection and Co-Infection Patterns of Community-Acquired Pneumonia in Patients of Different Ages in China from 2009 to 2020: A National Surveillance Study. The Lancet Microbe 2023; 4: e330–e339. [PubMed]
Farhadi F, Aliyari R, Ebrahimi H, et al. Prevalence of Uncontrolled Hypertension and Its associated Factors in 50-74 Years Old Iranian Adults: A Population-Based Study. BMC Cardiovasc Disord 2023; 23: 318. [PubMed]
Hassan A, Jasim A, Shlash J, et al. A Study of Patients with Cerebral Vascular Accident (CVA) Regarding to Risk Factors in Iraq. Bahrain Med Bull 2022; 44: 1063.
Abate BB, Kassie AM, Kassaw MW, et al. Sex Difference in Coronavirus Disease (COVID-19): A Systematic Review and Meta-Analysis. BMJ Open 2020; 10: e040129. [PubMed]
Hödlmoser S, Winkelmayer WC, Zee J, et al. Sex Differences in Chronic Kidney Disease Awareness among US Adults, 1999 to 2018. PLoS One 2020; 15: e0243431. [PubMed]
Sahuquillo-Arce JM, Menéndez R, Méndez R, et al. Age-Related Risk Factors for Bacterial Aetiology in Community-Acquired Pneumonia. Respirology 2016; 21: 1472–1479. [PubMed]
Ramadhaniah F, Sudaryo M, Syarif S. Metabolic Syndrome as a Risk for Coronary Heart Disease in Indonesia: A Longitudinal Study 2007-2014. Malaysian J Med Heal Sci 2022; 18: 86–92. [Journal]
Anderson R, Feldman C. The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy. Int J Mol Sci; 24. Epub ahead of print July 2023.[PubMed]
Miriti DM, Muthini JM, Nyamache AK. Study of Bacterial Respiratory Infections and Antimicrobial Susceptibility Profile among Antibiotics Naive Outpatients Visiting Meru Teaching and Referral Hospital, Meru County, Kenya in 2018. BMC Microbiol 2023; 23: 172. [PubMed]
John TM, Deshpande A, Brizendine K, et al. Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia. Open Forum Infect Dis 2022; 9: ofab597. [PubMed]
La Combe B, Clermont O, Messika J, et al. Pneumonia-Specific Escherichia coli with Distinct Phylogenetic and Virulence Profiles, France, 2012-2014. Emerg Infect Dis 2019; 25: 710–718. [PubMed]
Zhou Y, Du J, Wu J-Q, et al. Impact of Influenza Virus Infection on Lung Microbiome in Adults with Severe Pneumonia. Ann Clin Microbiol Antimicrob 2023; 22: 43. [PubMed]
Ashrafi-Asgarabad A, Bokaie S, Razmyar J, et al. The Burden of Lower Respiratory Infections and Their Underlying Etiologies in the Middle East and North Africa Region, 1990-2019: Results from the Global Burden of Disease Study 2019. BMC Pulm Med 2023; 23: 2. [PubMed]
Tokimatsu I, Matsumoto T, Tsukada H, et al. Nationwide Surveillance of Bacterial Respiratory Pathogens Conducted by the Surveillance Committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019-2020. J Infect Chemother 2023; 29: 731–743. [PubMed]
Breijyeh Z, Jubeh B, Karaman R. Molecules Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Mol Online; 25. Epub ahead of print 16 March 2020. [PubMed]
Shiralizadeh S, Keramat F, Hashemi SH, et al. Investigation of Antimicrobial Resistance Patterns and Molecular Typing of Pseudomonas aeruginosa Isolates among Coronavirus Disease-19 Patients. BMC Microbiol 2023; 23: 84. [Journal]
Almasaudi SB. Acinetobacter spp. as Nosocomial Pathogens: Epidemiology and Resistance Features. Saudi J Biol Sci 2018; 25: 586–596. [PubMed]
Copyright (c) 2024 Afan Fatkhur Akhmad, Maria Ulfa, Momoyo Azuma
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
JR (